Axiora Medical
Axiora Medical
Explore our elite selection of surgical instruments and locking plate systems engineered for precision osteotomy and trauma repair.
The global total elbow arthroplasty (TEA) market has undergone significant transformations, moving away from primitive hinge designs towards highly sophisticated semi-constrained and unconstrained systems. Modern elbow reconstruction surgery requires implants that can mimic the complex kinematics of the human elbow—a joint involving critical articulation between the humerus, ulna, and radius. Driven by an aging global population and the rising incidence of complex distal humerus nonunions, rheumatoid arthritis, and post-traumatic osteoarthritis, the demand for highly resilient implants has peaked.
Key clinical focus areas now center around reducing mechanical wear at the articulation interface and mitigating the risk of aseptic loosening, which historically plagued earlier designs. Advanced materials like ultra-high-molecular-weight polyethylene (UHMWPE) bushings combined with biocompatible titanium alloys (Ti-6Al-4V ELI) or Cobalt-Chromium-Molybdenum (CoCrMo) cores are setting new standards for durability. At the same time, modular designs that allow surgeons to convert an unconstrained system into a semi-constrained joint intraoperatively are gaining high clinical traction.
For global distributors, B2B procurement managers, and orthopedics brands, sourcing elbow and joint implants is not just about price—it is a balancing act between regulatory compliance, material verification, and absolute structural integrity. The primary purchasing friction points include compliance with regulatory standards such as CE MDR in Europe and FDA clearances in the Americas.
Importers require comprehensive documentation, including material mill certificates, bio-compatibility reports, and strict fatigue testing certificates. Axiora Medical Technology resolves these sourcing challenges by maintaining a highly audited production ecosystem. Our 100% inspection policy ensures that every humeral stem and ulnar articulation plate shipped exhibits structural reliability, dimensional accuracy measured down to the micrometer, and flawless surface finishes, preventing bone cement adhesion issues or premature mechanical failure.
Integrating Swiss-type CNC machining, robotic polishing, and Class 10,000 cleanrooms to secure global distribution pipelines.
Utilizing multi-axis longitudinal turning centers and vertical milling setups to sculpt bone-interfacing contours with tolerances of less than 5 microns. This ensures consistent anatomical fitment and seamless instrument engagement during surgeries.
Implementing controlled chemical oxidation of titanium surfaces to produce type II and type III anodized layers, yielding bio-inert properties, improved wear resistance, and distinct color-coding for surgical efficiency.
Packaging procedures are carried out within strictly regulated Class 100,000 (ISO Class 7/8) environmental zones. Cleanliness levels prevent pyrogenic contamination before final gamma or EO gas sterilization cycles.
Step-by-step visual display of our in-house production line, ensuring every orthopedic device meets strict medical guidelines.
Equipped with Swiss cutting machinery and computerized stress testing rigs to guarantee long-term implant survival rates.
Axiora Medical Technology (China) Co., Ltd. is a verified Class III medical manufacturer supplying high-performance surgical components to orthopedic hospitals globally.
Established with a deep commitment to surgical precision and metallurgical optimization, Axiora integrates multi-axis Swiss milling, specialized electro-polishing, and rigorous non-destructive evaluation (NDE) methodologies to supply the global orthopedic market.
Our comprehensive research facility in China supports major OEM projects from concept blueprinting to clinical-grade volume runs. Backed by 86 dedicated R&D engineers, we execute custom structural modifications, reverse engineering workflows, and localized instrument interface tuning.
Whether supplying custom locking humeral components or standard trauma instrumentation sets, Axiora’s integrated logistics support provides reliable shipping timelines, low defect rates, and comprehensive post-sale support.
| Operation Details | Axiora Medical Technical Standard |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Established Year & Location | 2017 - Jiangsu Industrial Development Zone, China |
| Factory Footprint | 18,600 Square Meters (Including Class 10,000 cleanroom spaces) |
| Quality Control Staff | 48 Dedicated QA/QC Technicians & NDT Inspectors |
| R&D Engineering Team | 86 Advanced Biomedical & Metallurgical Engineers |
| Testing Instrumentation | CMM, Laser Particle Counters, Accelerated Ageing Chambers, Tensile Fatigue Rigs |
| Export Revenue (Annual) | USD 26 Million (Serving Europe, North America, Middle East, & LatAm) |
| OEM/ODM Scope | Laser engraving, custom sizing, material adjustments, custom instrument kits |
How our orthopedic systems perform across medical centers, trauma facilities, and veterinary orthopedics.
Ideal for complex comminuted fractures of the distal humerus, nonunions, and arthroplasty revisions. Our rigid locking plates and custom joint spacers restore anatomical alignment and joint stability immediately post-op.
Customizable humeral and ulnar stems allow surgeons to select patient-specific dimensions. Modular stems ensure correct soft-tissue tensioning, reducing postoperative subluxation risk.
Our micro-locking plate systems and osteotomes are widely utilized by canine and feline orthopedic surgeons worldwide to repair complex limb deformities and joint trauma in small animals.
Technical answers regarding raw materials, supply chain processes, customization, and quality standards.
Discover our highly specialized veterinary systems, intramedullary tibial nails, and orthopedic power drills.
